Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.
<h4>Background</h4>The mainstays of cutaneous leishmaniasis (CL) treatment, in several world regions, are pentavalent antimony (Sbv) compounds administered parenterally, despite their recognized toxicity, which requires frequent laboratory monitoring and complicates their use in areas wi...
Saved in:
| Main Authors: | Nayara Castelano Brito, Ana Rabello, Gláucia Fernandes Cota |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0184777 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis
by: Pouran Layegh, et al.
Published: (2011-01-01) -
Treatment failure of pentavalent antimonial therapy for human visceral leishmaniasis: a meta-analysis
by: Caitlin M Jones, et al.
Published: (2019-12-01) -
The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-Analysis.
by: Gláucia Fernandes Cota, et al.
Published: (2016-01-01) -
Liposomal amphotericin B versus pentavalent antimony salts for visceral Leishmania in children
by: Hurşit Apa, et al.
Published: (2013-08-01) -
Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison.
by: Gláucia F Cota, et al.
Published: (2013-01-01)